209 related articles for article (PubMed ID: 21904776)
21. T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice.
Dargel C; Bassani-Sternberg M; Hasreiter J; Zani F; Bockmann JH; Thiele F; Bohne F; Wisskirchen K; Wilde S; Sprinzl MF; Schendel DJ; Krackhardt AM; Uckert W; Wohlleber D; Schiemann M; Stemmer K; Heikenwälder M; Busch DH; Richter G; Mann M; Protzer U
Gastroenterology; 2015 Oct; 149(4):1042-52. PubMed ID: 26052074
[TBL] [Abstract][Full Text] [Related]
22. [HBx gene down-regulates miR-192 expression and inhibits apoptosis of human hepatoma cell line HepG2].
Xie QH; He XX; Chang Y; Jiang X; Lin JS
Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):857-60. PubMed ID: 22433310
[TBL] [Abstract][Full Text] [Related]
23. [The target--gene expression of interleukin--12 in HepG2 cells].
Wang Z; Liang G; Fu S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Dec; 12(4):306-9, 329. PubMed ID: 12526339
[TBL] [Abstract][Full Text] [Related]
24. Octreotide inhibits proliferation and induces apoptosis of hepatocellular carcinoma cells.
Liu HL; Huo L; Wang L
Acta Pharmacol Sin; 2004 Oct; 25(10):1380-6. PubMed ID: 15456543
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of GPC3 inhibits hepatocellular carcinoma cell proliferation and invasion through induction of apoptosis.
Pan Z; Chen C; Long H; Lei C; Tang G; Li L; Feng J; Chen F
Mol Med Rep; 2013 Mar; 7(3):969-74. PubMed ID: 23338845
[TBL] [Abstract][Full Text] [Related]
26. [Impact of AFP promoter on the expressions of GFP in tumor cells].
Mao CQ; Huang CZ; Yang SD; Zhao M; Fan YX; Xu F; Du F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):495-8. PubMed ID: 12905870
[TBL] [Abstract][Full Text] [Related]
27. The significance of glypican-3 expression profiling in the tumor cellular origin theoretical system for hepatocellular carcinoma progression.
Xue R; Feng J; Meng Q; Lv F; Zhu Y; Yu H; Zhang S; Song C; Sun L; Yue Z; Feng S; Che R; Xiang Q; Jing X
J Gastroenterol Hepatol; 2017 Aug; 32(8):1503-1511. PubMed ID: 28087980
[TBL] [Abstract][Full Text] [Related]
28. [The inhibition effect and its molecular mechanism of human cervical cancer oncogene siRNA on hepatocarcinoma cells].
Yang Y; Zhou XF; Liu AD
Zhonghua Gan Zang Bing Za Zhi; 2008 Aug; 16(8):612-5. PubMed ID: 18752750
[TBL] [Abstract][Full Text] [Related]
29. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH
Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068
[TBL] [Abstract][Full Text] [Related]
30. Synergistic effect of IFN-γ gene on LIGHT-induced apoptosis in HepG2 cells via down regulation of Bcl-2.
Han B; Wu LQ; Ma X; Wang ZH; Li JP; Bi CY; Yong S
Artif Cells Blood Substit Immobil Biotechnol; 2011 Aug; 39(4):228-38. PubMed ID: 21117871
[TBL] [Abstract][Full Text] [Related]
31. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
32. Tumor-targeted gene therapy using Adv-AFP-HRPC/IAA prodrug system suppresses growth of hepatoma xenografted in mice.
Dai M; Liu J; Chen DE; Rao Y; Tang ZJ; Ho WZ; Dong CY
Cancer Gene Ther; 2012 Feb; 19(2):77-83. PubMed ID: 21959967
[TBL] [Abstract][Full Text] [Related]
33. Targeting alpha-fetoprotein represses the proliferation of hepatoma cells via regulation of the cell cycle.
Tang H; Tang XY; Liu M; Li X
Clin Chim Acta; 2008 Aug; 394(1-2):81-8. PubMed ID: 18485897
[TBL] [Abstract][Full Text] [Related]
34. [Short hairpin RNA mediated glypican-3 silencing inhibits hepatoma cell invasiveness and disrupts molecular pathways of angiogenesis].
Yu DD; Yao M; Chen J; Wang L; Yan MJ; Gu X; Qiu LW; Dong ZZ; Yao DF; Lu SL
Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):452-8. PubMed ID: 24034848
[TBL] [Abstract][Full Text] [Related]
35. GPC3 DNA vaccine elicits potent cellular antitumor immunity against HCC in mice.
Li SQ; Lin J; Qi CY; Fu SJ; Xiao WK; Peng BG; Liang LJ
Hepatogastroenterology; 2014; 61(130):278-84. PubMed ID: 24901124
[TBL] [Abstract][Full Text] [Related]
36. Expression of functional CD40 in human hepatocellular carcinoma.
Sugimoto K; Shiraki K; Ito T; Fujikawa K; Takase K; Tameda Y; Moriyama M; Nakano T
Hepatology; 1999 Oct; 30(4):920-6. PubMed ID: 10498643
[TBL] [Abstract][Full Text] [Related]
37. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
[TBL] [Abstract][Full Text] [Related]
38. The expression profile of glypican-3 and its relation to macrophage population in human hepatocellular carcinoma.
Takai H; Kato A; Kato C; Watanabe T; Matsubara K; Suzuki M; Kataoka H
Liver Int; 2009 Aug; 29(7):1056-64. PubMed ID: 19141032
[TBL] [Abstract][Full Text] [Related]
39. [Adeno-associated virus mediated tumor necrosis factor related apoptosis inducing ligand gene transfected into hepatocellular carcinoma cells by ultrasound microbubble intensifier: an experimental study].
Xia JT; Xu B; Wang SC; Lai YY; Wu ZF; Li SH; Li W
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1846-50. PubMed ID: 19040022
[TBL] [Abstract][Full Text] [Related]
40. [Construction and expression of eukaryotic expression vector for pEGFP-GPC3].
Liu CH; Zhang ZM; Liu JY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 May; 28(5):462-5. PubMed ID: 22558983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
